ATE238986T1 - 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga - Google Patents

1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga

Info

Publication number
ATE238986T1
ATE238986T1 AT98952587T AT98952587T ATE238986T1 AT E238986 T1 ATE238986 T1 AT E238986T1 AT 98952587 T AT98952587 T AT 98952587T AT 98952587 T AT98952587 T AT 98952587T AT E238986 T1 ATE238986 T1 AT E238986T1
Authority
AT
Austria
Prior art keywords
dihydroxy
dialkyl
vitamin
analogue
analogs
Prior art date
Application number
AT98952587T
Other languages
English (en)
Inventor
Percy Sarwood Manchand
Milan Radoje Uskokovic
Original Assignee
Hoffmann La Roche
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Hoffmann La Roche filed Critical Hoffmann La Roche
Application granted granted Critical
Publication of ATE238986T1 publication Critical patent/ATE238986T1/de

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/59—Compounds containing 9, 10- seco- cyclopenta[a]hydrophenanthrene ring systems
    • A61K31/593—9,10-Secocholestane derivatives, e.g. cholecalciferol, i.e. vitamin D3
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P19/00—Drugs for skeletal disorders
    • A61P19/08—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease
    • A61P19/10—Drugs for skeletal disorders for bone diseases, e.g. rachitism, Paget's disease for osteoporosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C401/00—Irradiation products of cholesterol or its derivatives; Vitamin D derivatives, 9,10-seco cyclopenta[a]phenanthrene or analogues obtained by chemical preparation without irradiation

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Physical Education & Sports Medicine (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Orthopedic Medicine & Surgery (AREA)
  • Rheumatology (AREA)
  • Epidemiology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
AT98952587T 1997-09-08 1998-09-02 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga ATE238986T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US5813297P 1997-09-08 1997-09-08
PCT/EP1998/005571 WO1999012894A1 (en) 1997-09-08 1998-09-02 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analogs

Publications (1)

Publication Number Publication Date
ATE238986T1 true ATE238986T1 (de) 2003-05-15

Family

ID=22014900

Family Applications (1)

Application Number Title Priority Date Filing Date
AT98952587T ATE238986T1 (de) 1997-09-08 1998-09-02 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga

Country Status (9)

Country Link
US (3) US6492353B1 (de)
EP (1) EP1015423B1 (de)
JP (1) JP4219553B2 (de)
AT (1) ATE238986T1 (de)
AU (1) AU1022999A (de)
CA (1) CA2303248A1 (de)
DE (1) DE69814109T2 (de)
ES (1) ES2196614T3 (de)
WO (1) WO1999012894A1 (de)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE19916419B4 (de) * 1999-04-08 2005-06-16 Schering Ag Kombinationspräparat aus Vitamin-D-Metaboliten oder Vitamin-D-Analoga und einem Östrogenpartialagonisten zur Behandlung von Osteoporose
EP1267886B1 (de) * 2000-03-27 2006-03-08 Wisconsin Alumni Research Foundation Vitamin d-verbindungen zur behandlung von chronischer tranplantatnephropathie bei nieren transplantieren patienten
US7524969B2 (en) * 2001-01-26 2009-04-28 Chugai Seiyaku Kabushiki Kaisha Malonyl-CoA decarboxylase inhibitors useful as metabolic modulators
DE60229240D1 (de) * 2001-05-22 2008-11-20 Bioxell Spa Verwendung eines analoges des vitamins d3 zur behandlung des autoimmunen diabetes
EP1430026A1 (de) * 2001-09-21 2004-06-23 F. Hoffmann-La Roche Ag Ester von 3-desoxy-vitamin-d3-analoga
US20050107350A1 (en) * 2003-08-22 2005-05-19 Pharmacia Corporation Method for the treatment or prevention of bone disorders with a cyclooxygenase-2 inhibitor alone and in combination with a bone disorder treatment agent and compositions therewith
WO2005030222A1 (en) * 2003-09-24 2005-04-07 Bioxell S.P.A. 1,3-diaclyated,26,27-alkyl/haloalkyl vitamin d3 compounds and methods of use thereof
EP1797033A4 (de) * 2004-09-24 2010-04-28 Bioxell Spa 20-cycloalkyl-26,27-alkyl/halogenalkyl-vitamin-d3-verbindungen und verfahren zu deren anwendung
CA2586679A1 (en) 2004-11-12 2006-05-18 Bioxell Spa Combined use of vitamin d derivatives and anti-proliferative agents for treating bladder cancer
JP4961562B2 (ja) * 2005-03-04 2012-06-27 国立大学法人 東京医科歯科大学 １９−ノルビタミンｄ誘導体
WO2007039322A1 (en) * 2005-09-19 2007-04-12 Bioxell Spa Use of vitamin d3 compounds for the treatment of uveitis
US8415390B2 (en) 2008-05-30 2013-04-09 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
US9119777B2 (en) 2008-05-30 2015-09-01 Microdose Therapeutx, Inc. Methods and compositions for administration of oxybutynin
JP2013538830A (ja) * 2010-09-27 2013-10-17 マイクロドース セラピューテクス，インコーポレイテッド 吸入を用いる疾患治療のための方法及び組成物
EP2682386B1 (de) * 2011-03-02 2016-08-17 Nihon University Neuer vitamin-d-rezeptormodulator mit partieller agonistischer wirkung

Family Cites Families (18)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4804502A (en) 1988-01-20 1989-02-14 Hoffmann-La Roche Inc. Vitamin D compounds
US5087619A (en) * 1988-01-20 1992-02-11 Hoffman-La Roche Inc. Vitamin D3 analogs
EP0412110B1 (de) * 1988-04-21 1993-07-07 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Produktionsaktieselskab) Vitamin d analoge
US4851401A (en) * 1988-07-14 1989-07-25 Wisconsin Alumni Research Foundation Novel cyclopentano-vitamin D analogs
US5401731A (en) * 1989-06-29 1995-03-28 Leo Pharmaceutical Products Ltd. A/S (Lovens Kemiske Fabrik Productionsaktieselskab) Vitamin D analogues
GB9017890D0 (en) * 1990-08-15 1990-09-26 Leo Pharm Prod Ltd Chemical compounds i
DK0521550T3 (da) 1991-07-05 1996-11-04 Duphar Int Res Vitamin D forbindelse, fremgangsmåde til fremstilling af denne forbindelse og mellemprodukt derfor
DE4141746A1 (de) 1991-12-13 1993-06-17 Schering Ag 20-methyl-substituierte vitamin d-derivate
ATE141914T1 (de) * 1992-05-20 1996-09-15 Hoffmann La Roche Fluorierte analoge vitamins d3
DE4220757A1 (de) * 1992-06-24 1994-01-05 Schering Ag Derivate in der Vitamin D-Reihe mit Modifikationen in der 20-Position, Verfahren zu ihrer Herstellung, Zwischenprodukte für dieses Verfahren, diese Derivate enthaltende pharmazeutische Präparate sowie deren Verwendung zur Herstellung von Arzneimitteln
IL107185A (en) 1992-10-06 1998-02-22 Schering Ag Vitamin d, 25-carboxylic acid derivatives and pharmaceutical compositions containing the same
CA2096105A1 (en) * 1992-10-07 1994-04-08 Enrico Giuseppe Baggiolini (Deceased) Vitamin d3 fluorinated analogs
DE69433220T2 (de) * 1993-07-09 2004-08-19 Laboratoire Theramex Neue strukturelle Vitamin D Derivate
US5552392A (en) * 1993-11-03 1996-09-03 Wisconsin Alumni Research Foundation Method of treating hypoparathyroidism with (20S) vitamin D compounds
US5428029A (en) * 1993-11-24 1995-06-27 Hoffmann-La Roche Inc. Vitamin D3 fluorinated analogs
DK0832063T3 (da) * 1995-06-14 2000-06-13 Schering Ag Vitamin D-derivater med substituenter på C-25, fremgangsmåde til deres fremstilling, mellemprodukter samt deres anvendelse
NO971934L (no) * 1996-05-23 1997-11-24 Hoffmann La Roche Flourinerte vitamin D3 -analoger
CA2289209C (en) * 1997-05-16 2006-07-25 Women & Infants Hospital Cyclic ether vitamin d3 compounds, 1.alpha. (oh) 3-epi-vitamin d3 compounds and uses thereof

Also Published As

Publication number Publication date
US6492353B1 (en) 2002-12-10
WO1999012894A1 (en) 1999-03-18
AU1022999A (en) 1999-03-29
JP2001515881A (ja) 2001-09-25
EP1015423B1 (de) 2003-05-02
EP1015423A1 (de) 2000-07-05
CA2303248A1 (en) 1999-03-18
US20040167105A1 (en) 2004-08-26
ES2196614T3 (es) 2003-12-16
JP4219553B2 (ja) 2009-02-04
DE69814109T2 (de) 2004-02-26
DE69814109D1 (de) 2003-06-05
US20030083319A1 (en) 2003-05-01

Similar Documents

Publication Publication Date Title
ATE238986T1 (de) 1,3-dihydroxy-20,20-dialkyl-vitamin d3 analoga
YU18400A (sh) Prostaglanidin agonisti i njihova primena za tretiranje koštanih poremećaja
LU91145I9 (de)
AP9801269A0 (en) Prostaglandin agonists.
DK1914237T3 (da) Antivirale fosfonatesterforbindelser
UA39158C2 (uk) Похідні n4-оксикарбоніл-5'-дезокси-5-фторцитидину та фармацевтичний препарат на їх основі
EP0911321A3 (de) Verbindungen zur Behandlung von Osteoporose
BR9911488A (pt) Composto, uso do mesmo, composição farmacêutica, e, processos para tratamento ou de profilaxia de doenças inflamatórias, e para a preparação de um composto
GB0004128D0 (en) Novel compounds
AP9200410A0 (en) Retroviral protease inhibitors.
NZ503308A (en) Alpha-ketoamide multicatalytic protease inhibitors
PT2009025E (pt) Método de inibição da actividade dos osteoclastos
FR2757857B1 (fr) Diselenures et selenosulfures aromatiques, leur preparation et leurs utilisations, notamment therapeutiques
ES8609312A1 (es) Procedimiento para la preparacion de silibinina exenta de isosilibina
NO20014241D0 (no) C16-umettede FP-selektive prostaglandinanaloger
AU4011300A (en) Compositions and methods for the treatment of immune related diseases
DE69715173D1 (en) Bisarylcyclobutenderivate als cyclooxygenasehemmer
AU623805B2 (en) New use of anti-progestomimetic compounds
MXPA03008801A (es) Aril oxima-piperazinas utiles como antagonistas de ccr5.
BG101116A (en) Pyridylbisphosphonates and their use as therapeutical means
AU6826700A (en) Ceramide analogs, process for their preparation and their use as antitumor agents
MY118946A (en) Novel intermediates and their use to prepare n, n''- bridged bisindolylmaleimides
MXPA03010737A (es) Aril-8-azabiciclo(3.2.1) octanos para tratamiento de depresion.
TR200002293T2 (tr) Farmasötik bileşimler.
GB9015774D0 (en) Novel treatment

Legal Events

Date Code Title Description
RER Ceased as to paragraph 5 lit. 3 law introducing patent treaties